St. Joe Co
Change company Symbol lookup
Select an option...
JOE St. Joe Co
OMC Omnicom Group Inc
CHDN Churchill Downs Inc
SGTB Kuboo Inc
BBBMX BBH Limited Duration Fund Class N
VICI VICI Properties Inc
DDS Dillard's Inc
ALIN-E Altera Infrastructure LP
AUVGF Australian Vintage Ltd
LQSIF Alcanna Inc
Go

Real Estate : Real Estate Management & Development | Small Cap Growth
Company profile

The St. Joe Company is a real estate development, asset management and operating company. The Company operates through five segments: residential real estate; commercial real estate; resorts and leisure; leasing operations, and forestry. Its residential real estate segment plans and develops primary residential and resort residential communities of various sizes on its existing land. Its commercial real estate segment plans, develops, manages and sells real estate. Resorts and leisure segment features a portfolio of vacation rentals and hotel operations, as well as golf courses, a beach club, marinas and other related resort amenities. Its leasing operations business includes its retail and commercial leasing. Its forestry segment focuses on the management of its timber holdings in Northwest Florida.

Closing Price
$47.16
Day's Change
0.99 (2.14%)
Bid
--
Ask
--
B/A Size
--
Day's High
47.29
Day's Low
45.62
Volume
(Above Average)
Volume:
238,016

10-day average volume:
215,786
238,016

Revive Adjourns Annual and Special Meeting

2:49 pm ET April 12, 2021 (Globe Newswire) Print

Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announces that its Annual and Special Meeting (the "Meeting") scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021 will be adjourned to a future date.

Due to the current provincial lockdown in response to the COVID-19 pandemic, the Meeting was to be held by way of conference call. Due to the high shareholder turnout and interest, the service provider contracted to arrange the conference call experienced technical difficulties with the bridge facilities. In order to ensure that all shareholders are able to attend and participate at the Meeting, the Company has decided to adjourn the Meeting in order to procure enhanced conference facilities. A subsequent press release will be disseminated with the updated call-in information.

About Revive Therapeutics Ltd.

Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of infectious diseases, with an initial focus on COVID-19. With its recent acquisition of Psilocin Pharma Corp., Revive is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. Revive's cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the company was granted FDA orphan drug status designation for the use of Cannabidiol to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation. For more information, visit www.ReviveThera.com.

For more information please contact:
Michael Frank
Chief Executive Officer
Revive Therapeutics Ltd.
Tel:               1 888 901 0036
Email:             mfrank@revivethera.com
Website:           www.revivethera.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.

https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png

https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.